Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned

International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the con...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Degaga, TS, Weston, S, Tego, TT, Abate, DT, Aseffa, A, Wayessa, A, Price, RN, Hailu, A, Thriemer, K
Format: Journal article
Sprache:English
Veröffentlicht: BioMed Central 2020
_version_ 1826280916146716672
author Degaga, TS
Weston, S
Tego, TT
Abate, DT
Aseffa, A
Wayessa, A
Price, RN
Hailu, A
Thriemer, K
author_facet Degaga, TS
Weston, S
Tego, TT
Abate, DT
Aseffa, A
Wayessa, A
Price, RN
Hailu, A
Thriemer, K
author_sort Degaga, TS
collection OXFORD
description International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the context. The investigators of a multicentre anti-malarial clinical trial (the IMPROV study) conducted a dissemination meeting at one of the study sites in Ethiopia; trial participants and medical staff were provided feedback on the study results. This report summarizes the dissemination strategies adopted by the investigators, including a plain language visual aid and simple communication techniques. Lessons learned are reported with a discussion on the operational challenges to dissemination of clinical trials in resource limited settings.
first_indexed 2024-03-07T00:20:55Z
format Journal article
id oxford-uuid:7c80ed0c-88e7-4908-8a08-03f53b194174
institution University of Oxford
language English
last_indexed 2024-03-07T00:20:55Z
publishDate 2020
publisher BioMed Central
record_format dspace
spelling oxford-uuid:7c80ed0c-88e7-4908-8a08-03f53b1941742022-03-26T20:57:34ZDisseminating clinical study results to trial participants in Ethiopia: insights and lessons learnedJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7c80ed0c-88e7-4908-8a08-03f53b194174EnglishSymplectic ElementsBioMed Central2020Degaga, TSWeston, STego, TTAbate, DTAseffa, AWayessa, APrice, RNHailu, AThriemer, KInternational regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the context. The investigators of a multicentre anti-malarial clinical trial (the IMPROV study) conducted a dissemination meeting at one of the study sites in Ethiopia; trial participants and medical staff were provided feedback on the study results. This report summarizes the dissemination strategies adopted by the investigators, including a plain language visual aid and simple communication techniques. Lessons learned are reported with a discussion on the operational challenges to dissemination of clinical trials in resource limited settings.
spellingShingle Degaga, TS
Weston, S
Tego, TT
Abate, DT
Aseffa, A
Wayessa, A
Price, RN
Hailu, A
Thriemer, K
Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
title Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
title_full Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
title_fullStr Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
title_full_unstemmed Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
title_short Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
title_sort disseminating clinical study results to trial participants in ethiopia insights and lessons learned
work_keys_str_mv AT degagats disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT westons disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT tegott disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT abatedt disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT aseffaa disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT wayessaa disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT pricern disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT hailua disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned
AT thriemerk disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned